In a landmark move for Thailand’s medical landscape, the Health Systems Research Institute (HSRI) and AstraZeneca (Thailand) Co., Ltd. have forged a powerful partnership through a recently signed Memorandum of Understanding (MOU). This collaboration, centered on advancing clinical research within
Endometrial cancer (EC), recognized as the most prevalent gynecologic malignancy in high-income nations, continues to pose a significant public health challenge with its incidence on a steady rise, largely fueled by escalating obesity rates and other modifiable lifestyle factors. The stakes for
Imagine a world where a tiny robot, smaller than a grain of sand, can navigate the intricate maze of blood vessels in the human brain to deliver life-saving medication exactly where it’s needed, avoiding the dangerous side effects of traditional treatments. This isn’t science fiction but a
Imagine a world where life-saving medicines are developed at an unprecedented pace, cutting through years of trial and error to deliver treatments to patients in record time, thanks to a groundbreaking partnership between a leading pharmaceutical company and a technology powerhouse. Their
In the realm of respiratory care, long-term oxygen therapy (LTOT) stands as a critical intervention for patients grappling with severe hypoxemia, particularly those diagnosed with chronic obstructive pulmonary disease (COPD). This treatment, aimed at boosting survival by correcting dangerously low
In a world increasingly threatened by antibiotic resistance, the emergence of Klebsiella pneumoniae as a major health hazard has sounded alarms across medical communities globally, highlighting the urgent need for innovative solutions. This bacterial pathogen, notorious for causing severe
